MedTech Acquisition Corp Alpha and Beta Analysis
| MTACDelisted Stock | USD 10.55 0.03 0.28% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as MedTech Acquisition Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in MedTech Acquisition over a specified time horizon. Remember, high MedTech Acquisition's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to MedTech Acquisition's market risk premium analysis include:
Beta (0.15) | Alpha 0.0424 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
MedTech |
MedTech Acquisition Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. MedTech Acquisition market risk premium is the additional return an investor will receive from holding MedTech Acquisition long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in MedTech Acquisition. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate MedTech Acquisition's performance over market.| α | 0.04 | β | -0.15 |
MedTech Acquisition Fundamentals Vs Peers
Comparing MedTech Acquisition's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze MedTech Acquisition's direct or indirect competition across all of the common fundamentals between MedTech Acquisition and the related equities. This way, we can detect undervalued stocks with similar characteristics as MedTech Acquisition or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of MedTech Acquisition's fundamental indicators could also be used in its relative valuation, which is a method of valuing MedTech Acquisition by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare MedTech Acquisition to competition |
| Fundamentals | MedTech Acquisition | Peer Average |
| Return On Asset | -0.0193 | -0.14 |
| Current Valuation | 79.84 M | 16.62 B |
| Shares Outstanding | 7.39 M | 571.82 M |
| Shares Owned By Insiders | 84.51 % | 10.09 % |
| Shares Owned By Institutions | 17.16 % | 39.21 % |
| Number Of Shares Shorted | 2.85 K | 4.71 M |
| Price To Earning | 31.28 X | 28.72 X |
MedTech Acquisition Opportunities
MedTech Acquisition Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Surgical robotics startup Momentis cutting 60 percent of team one year ... - CTech | 05/08/2023 |
2 | Sanara MedTech Inc. Announces First Quarter 2023 Results - GlobeNewswire | 05/15/2023 |
3 | 400 Grail test users incorrectly told they may have cancer - FierceBiotech | 06/06/2023 |
4 | TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD Method with the TriNav Device for Uveal Melanoma Liver Metastases a... | 06/12/2023 |
5 | BD sells off surgical instruments unit to Steris for 540M - FierceBiotech | 06/20/2023 |
6 | Transcatheter Aortic Valve Implantation Market Share and ... - Digital Journal | 07/12/2023 |
7 | Johnson Johnson Stock Just Got A Surprising New Price Target - jacksonprogress-argus | 07/20/2023 |
About MedTech Acquisition Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including MedTech or other delisted stocks. Alpha measures the amount that position in MedTech Acquisition Corp has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards MedTech Acquisition in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, MedTech Acquisition's short interest history, or implied volatility extrapolated from MedTech Acquisition options trading.
Build Portfolio with MedTech Acquisition
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in MedTech Stock
If you are still planning to invest in MedTech Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MedTech Acquisition's history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |